Journal of the Korea Academia-Industrial cooperation Society (한국산학기술학회논문지)

The Korea Academia-Industrial cooperation Society (한국산학기술학회)
권호 표지
DOI QR코드

DOI QR Code

The impact of the patent through open innovation on the performance of the pharmaceutical and biotechnology firms

글로벌 제약·바이오 기업의 개방형 혁신 특허가 기업 성과에 미치는 영향

  • Lee, Byoungho (Daegu-Gyeongbuk Medical Innovation Foundation(DGMIF)) ;
  • Lee, Sang-Won (School of Pharmacy, Sungkyunkwan University)
  • 이병호 (대구경북첨단의료산업진흥재단) ;
  • 이상원 (성균관대학교 약학대학)
  • Received : 2017.08.22
  • Accepted : 2017.09.15
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Most studies of the effects of corporate patents on managerial performance conducted to date have been based on internally-generated patents. However, global pharmaceutical and biotechnology companies acquire patents not only from internal research and development (R&D), but also through university-industry collaboration and purchase. Focusing on this issue, our study collected patents from various sources, including internal R&D, purchased patents, and university-industry collaboration, to examine the real effects more accurately. Additionally, our study used a finite time lag model to consider the time lag between patent and corporate performance. The results of the quantitative analysis of the relationship between patents and corporate financial performance revealed that patent quantitative levels had less impact on sales than other types. However, quantitative patents levels appeared to have a significant impact on market value. Moreover, quantitative patent levels appeared to moderate impact on corporate profit. Patents acquired by internal R&D had the greatest impact on market value, while purchased patents had the greatest impact on corporate profit and sales. The purchased patents had a significant effect on financial performance in the pharmaceutical and biotechnology companies because of the long time required and expense associated with R&D. Overall, the results of this study provide the basis for global pharmaceutical and biotechnology companies to configure an optimal patent portfolio.

본 연구는 글로벌 제약 및 바이오 기업을 대상으로 내부특허, 산학특허, 매입특허의 양적 수준이 경영성과에 미치는 영향을 분석함으로써 내부특허 중심으로만 이루어진 기존연구들의 단점을 보완하고자하였다. 기존의 연구방식으로는 산학협력 및 매입을 통해 특허를 확보하고 있는 글로벌 대기업들의 경영성과를 설명하는데 어려움이 있었다. 특히 제약 및 바이오 기업의 경우 M&A를 통한 특허의 매입이 빈번히 일어나고 있어 매입 특허의 분석이 매우 중요함에도 불구하고 하나하나의 특허 명세서를 추적해 권리관계의 변동을 조사해야하는 어려움 때문에 연구가 진행되지 못했었다. 또한 연구방법 측면에서도 기존 성장모형에 특허가 경영성과에 영향을 주는데 걸리는 시간을 감안해 t-3년까지의 유한 시차를 고려한 확장모형을 제시했다. 분석결과 양적 특허수준은 매출에 미치는 영향은 적었고 시장가치에 상대적으로 큰 영향을 미쳤으며 수익에는 중간 정도의 영향력을 미쳤다. 3가지 특허중 기업의 시장가치에는 내부특허가 가장 큰 영향력을 미쳤고 매출과 수익에는 매입특허가 가장 큰 영향력을 나타내었다. 제약 바이오 기업에 있어서 매입특허가 경영성과에 중요한 영향을 미치는 것으로 나오는 이유는 제약 및 바이오 기업의 연구개발이 오랜 시간과 비용이 소요되며, 여러 가지 기술의 융복합이 필요한 연구이기 때문에 빠른 시간 안에 기술을 확보하는 것이 중요하고 이를 위해 기업들이 특허를 매입하거나 M&A를 함으로써 문제를 해결하고 있기 때문으로 판단되어진다. 본 연구는 글로벌 제약 및 바이오 기업들이 최적 특허 포트폴리오 구성을 할 수 있도록 도움을 줄 수 있을 것으로 기대한다.

Keywords

References

  1. Schumpeter, J. A., The theory of economic development: An inquiry into profits, capital, credit, interest, and the business cycle, New Jersey: Transaction Publishers, 1934.
  2. Awais M., et al., Current Status of Biotechnology in Health, American-Eurasian J. Agric. & Environ. Sci., 7, 2, pp. 210-220, 2010.
  3. Curren C. & Lecker J., Patent Indicators for Monitoring Convergence Examples from NFF and ICT, Technological Forecasting and Social Change, 78, pp. 256-273, 2011. DOI: https://doi.org/10.1016/j.techfore.2010.06.021
  4. Hacklin F., Coevolutionary Cycles of Convergence: An Extrapolation from the ICT Industry, Technological Forecasting and Social Change, 76, pp. 723-736, 2009. DOI: https://doi.org/10.1016/j.techfore.2009.03.003
  5. CHESBROUGH, Henry William, Open innovation: The new imperative for creating and profiting from technology, Harvard Business Press, 2003.
  6. Huston, L. & Sakkab, N., P&G's new innovation model, Harvard Business Review, 84, 3, 2006.
  7. Tennenhouse, D., Intel's open collaborative model of Industry-university research, Research Technology Management, 47, 4, pp. 269-276, 2004.
  8. Waites, R. & Dies, G., Corporate research and venture capital can learn from each other, Research Technology Management, 49, 2, 2006.
  9. Bruce, M., et al., Success factors for collaborative product development: a study of suppliers of information and communication technology, R&D Management, 25, 1, pp. 33-44, 1995. DOI: https://doi.org/10.1111/j.1467-9310.1995.tb00898.x
  10. Faems, D., et al., Interorganizational collaboration and innovation: Toward a portfolio approach, Journal of Product Innovation Management, 22, 3, pp. 238-250, 2005. DOI: https://doi.org/10.1111/j.0737-6782.2005.00120.x
  11. Nieto, M. J. & Santamaria, L., The importance of diverse collaborative networks for the novelty of product innovation, Technovation, 27, 6, pp. 367-377, 2007. DOI: https://doi.org/10.1016/j.technovation.2006.10.001
  12. JUNG, Mi-Ae; CHOI, Youn-Hee; HEO, Eunnyeong. Relationship between Innovative Capacities and IPR Performances among Korean Bio-firms, The Korean Economic Review, 55, 4, pp. 243-273, 2007.
  13. HALL, Bronwyn H.; JAFFE, Adam; TRAJTENBERG, Manuel. Market value and patent citations, RAND Journal of economics, pp. 16-38, 2005.
  14. Hall, B. H., et al., Market Value and Patent Citations: A First Look, Cambridge, MA: NBER publications, 2000. DOI: https://doi.org/10.3386/w7741
  15. Pakes, A., On Patents, R and D, and the Stock Market Rate of Return, Journal of Political Eonomy, 93, 2, pp. 390-409, 1985. DOI: https://doi.org/10.1086/261305
  16. NARIN, Francis; NOMA, Elliot; PERRY, Ross, Patents as indicators of corporate technological strength, Research policy, 16, 2-4, pp. 143-155, 1987. https://doi.org/10.1016/0048-7333(87)90028-X
  17. LEE, Byoungho; SHIN, Juneseuk. Effects of Outside-in Patents of Global Information Technology Companies on Corporate Performance, The Journal of Intellectual Property, 10, 2, pp. 161-194, 2015.
  18. LICHTENTHALER, Ulrich. Open innovation: Past research, current debates, and future directions, The Academy of Management Perspectives 25, 1, pp.75-93, 2011. DOI: https://doi.org/10.5465/AMP.2011.59198451
  19. CHESBROUGH, Henry William. Researching a New Paradigm, Oxford University Press, 2006
  20. YUN, JinHyo Joseph, et al., Introduction of an objective model to measure open innovation and its application to the information technology convergence sector, International Journal of Technology, Policy and Management 7, 14, 4, pp. 383-400, 2014. https://doi.org/10.1504/IJTPM.2014.065025
  21. AHN, Yeon Shick, An empirical analysis about the effect on performance of firm's patent competency: focusing on the high performance venture firms in Korea', Knowledge Management Research, 11, 1, pp. 83-96, 2010.
  22. HALL, Bronwyn H.; JAFFE, Adam B.; TRAJTENBERG, Manuel. Market value and patent citations: A first look, National Bureau of Economic Research, 36, 1, pp. 16-38, 2000.
  23. LIM, Ji-Youn; KIM, Chul-Young; GU, Ja-Chul, Analysis of Causal Relationship between Patent Indicators and Firm Performance, Korean Management Science Review, 28, 2, pp. 63-74, 2011.
  24. AUSTIN, David H., An event-study approach to measuring innovative output: The case of biotechnology, The American economic review, 83, 2, pp. 253-258, 1993.
  25. COMANOR, William S.; SCHERER, Frederic M., Patent statistics as a measure of technical change, Journal of political economy, 77, 3, pp. 392-398, 1969. DOI: https://doi.org/10.1086/259522
  26. ERNST, Holger, Patenting strategies in the German mechanical engineering industry and their relationship to company performance, Technovation, 15, 4, pp. 225-240, 1995. DOI: https://doi.org/10.1016/0166-4972(95)96605-S
  27. SCHERER, Frederic M., Firm size, market structure, opportunity, and the output of patented inventions, The American Economic Review, 55, 5, pp. 1097-1125, 1965.
  28. KIM, Sung-Ho; Kwak, Soo-Hwan; Kang Min-Cheol, A Positive Study on the Results of Patent Management Using Patent Indicator, Jounal of Finance and Knowledge Studies, 3, 1, pp. 106-128, 2005
  29. PAKES, Ariel; GRILICHES, Zvi, Patents and R&D at the firm level: a first look. In: R&D, patents, and productivity. University of Chicago Press, 1984. pp. 55-72.
  30. PARK, Jun-su, Study with proof on the influence on enterprise value of public announcement of obtaining a patent : with centering around KOSDAQ Market, doctorate thesis, Dankook University, p. 98, 2003.
  31. PARK, Sun-Young; PARK, Hyun-Woo; CHO, Man-Hyung. The Relationship between Technology Innovation and Firm Performance of Korean Companies based on Patent Analysis, Journal of Korea Technology Innovation Society, 9, 1, pp. 1-25, 2006.
  32. LEE, Ki-Hwan; YOON, Byung-Seop, The Effects of Patents on Firm Value: Venture vs. non-Venture, Journal of Technology Innovation, 14, 1, pp. 67-99, 2006.
  33. CREPON, Bruno; DUGUET, Emmanuel; MAIRESSEC, Jacques, Research, Innovation And Productivity: An Econometric Analysis At The Firm Level. Economics of Innovation and new Technology, 7, 2, pp. 115-158, 1998. DOI: https://doi.org/10.1080/10438599800000031
  34. HALL, Bronwyn H., Innovation and productivity, National bureau of economic research, p. 35, 2011.
  35. GRILICHES, Zvi; SCHMOOKLER, Jacob., Inventing and maximizing, The American Economic Review, 53, 4, pp. 725-729, 1963.
  36. COHEN, Wesley M.; LEVINTHAL, Daniel A., Absorptive capacity: A new perspective on learning and innovation, Administrative science quarterly, pp. 128-152, 1990.
  37. KIRK, Colleen P.; RAY, Ipshita; WILSON, Berry., The impact of brand value on firm valuation: The moderating influence of firm type, Journal of Brand Management, 20.6, pp. 488-500, 2013. DOI: https://doi.org/10.1057/bm.2012.55